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Abstract
Flaviviruses are small, capped positive sense RNA viruses that replicate in the cytoplasm of infected cells. Dengue virus and
other related flaviviruses have evolved RNA capping enzymes to form the viral RNA cap structure that protects the viral
genome and directs efficient viral polyprotein translation. The N-terminal domain of NS5 possesses the methyltransferase
and guanylyltransferase activities necessary for forming mature RNA cap structures. The mechanism for flavivirus
guanylyltransferase activity is currently unknown, and how the capping enzyme binds its diphosphorylated RNA substrate is
important for deciphering how the flavivirus guanylyltransferase functions. In this report we examine how flavivirus NS5 N-
terminal capping enzymes bind to the 59 end of the viral RNA using a fluorescence polarization-based RNA binding assay.
We observed that the KD for RNA binding is approximately 200 nM Dengue, Yellow Fever, and West Nile virus capping
enzymes. Removal of one or both of the 59 phosphates reduces binding affinity, indicating that the terminal phosphates
contribute significantly to binding. RNA binding affinity is negatively affected by the presence of GTP or ATP and positively
affected by S-adensyl methoninine (SAM). Structural superpositioning of the dengue virus capping enzyme with the
Vaccinia virus VP39 protein bound to RNA suggests how the flavivirus capping enzyme may bind RNA, and mutagenesis
analysis of residues in the putative RNA binding site demonstrate that several basic residues are critical for RNA binding.
Several mutants show differential binding to 59 di-, mono-, and un-phosphorylated RNAs. The mode of RNA binding appears
similar to that found with other methyltransferase enzymes, and a discussion of diphosphorylated RNA binding is
presented.
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Introduction
Dengue viruses are members of the Flaviviridae family (genus
Flavivirus), which are small RNA viruses of 10–11 Kb in length
with capped non-polyadenylated positive strand genomes. Dengue
virus proteins are produced from a single open reading frame via
translation of the genomic viral RNA as a single polyprotein that
is co-translationally processed into 3 structural proteins (Capsid,
prM, and Envelope) and 8 non-structural proteins (NS1, NS2A,
NS2B, NS3, NS4A, 2K, NS4B, and NS5). The non-structural
proteins are responsible for directing viral genomic RNA
replication, including synthesizing negative- and positive-strand
RNAs and forming the viral RNA cap structure.
The flavivirus RNA cap is critical for viral polyprotein
translation and RNA replication. The RNA cap allows the viral
RNA to be efficiently translated by the cellular translational
machinery and provides protection for the genome from cellular
exonucleases. Flavivirus genomic RNA replication occurs on
rough endoplasmic reticulum membranes in membranous com-
partments away from the cellular capping machinery, requiring
the viruses to develop a mechanism for generating an RNA cap
structure. Dengue and other flaviviruses have evolved a complete
RNA capping machinery to form an RNA cap on the 59 end of the
positive-strand genomic RNA. Cellular RNA cap structures are
formed via the action of an RNA triphosphatase (RTPase),
guanylyltransferase (GTase), N7-methyltransferase (N7-MTase),
and 29-O methyltransferase (29O-MTase) [1]. Flavivirus genomic
RNA is modified at the 59 end of positive strand genomic RNA
with a cap 1 structure (me
7-GpppA-me
2) generated by the virus
encoded RTPase (NS3), GTase (NS5), 29-OMTase (NS5), and
Guanine-N7-MTase (NS5) [2,3,4,5,6,7,8,9]. X-ray crystal struc-
tures for each of these viral enzymes have been solved [3,8,10,11]
providing a wealth of information about how these enzymes may
function. The RTPase resides within the helicase domain of NS3
and appears to utilize the helicase ATP hydrolysis site to remove
the c-phosphate from the 59 end of the RNA [12]. The NS5 N-
terminal capping enzyme domain (dengue virus NS5 AA 1–265)
possesses the 29-O-MTase, Guanine-N7-MTase, and GTase
activities and the NS5 C-terminal domain possesses the RNA
dependent RNA polymerase [7,8,13,14,15,16,17].
During the GTase reaction, the NS5 N-terminal capping
enzyme must bind to the 59 end of the viral RNA. The GTase
reaction uses two substrates, a covalently bound guanosine
monophosphate (GMP) and the diphosphorylated 59 end of the
viral genomic RNA, to form the cap 0 structure (59 GpppA-
GUAA…). We and others have studied how the capping enzyme
binds GTP [8,11] and the RNA requirements for cap methylation
have been explored [16,17], but there is no empirical evidence for
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substrate for the GTase reaction. The current location of the RNA
binding region has been suggested based on the presence of basic
residues and in silico molecular dynamics docking of an RNA into
the crystal structure of the dengue capping enzyme [18]. A recent
structure of the dengue virus type 3 capping enzyme in complex
with an octomeric capped RNA demonstrated interactions
between the guanosine cap structure and the capping enzyme
showed no interactions between the RNA and the capping enzyme
putative RNA binding region [19]. This structure may represent
the post-capping product, but does not shed light onto how the
capping enzyme may bind diphosphorylated RNA during
capping. The flavivirus NS5 capping enzyme does not encode a
canonical Kx[D/N]G motif or any other known GTase motifs
[20,21,22,23]. Since the flavivirus capping enzyme is able to form
a guanylated intermediate (a GMP linked to the protein via a
phosphoamide bond) and transfer GMP to a diphosphorylated
RNA [7], it stands to reason that the capping enzyme must have a
non-canonical GTase motif. Understanding how the capping
enzyme binds its diphosphorylated RNA substrate is critical for
deciphering how this non-canonical GTase functions, but at this
point how it binds diphosphorylated RNA is unclear.
In this manuscript we examine the binding of the viral 59
diphosphorylated RNA substrate to the dengue virus capping
enzyme. We developed a fluorescence polarization-based RNA
binding assay to monitor the association of a short dipho-
sphorylated RNA corresponding to the conserved 59 end of the
flavivirus genome and determined the RNA binding affinity to the
capping enzyme. We assessed the effects of the various ligands
used by the capping enzyme on RNA binding affinity, and
determined that binding is negatively affected by GTP and ATP
and positively affected by SAM. We also performed a structure-
directed mutational analysis of the dengue 2 capping enzyme to
determine which amino acids may be involved with RNA binding
based on the structural similarity of the dengue virus capping
enzyme with the Vaccinia virus VP39 methyltransferase protein
bound to RNA. We identified several residues that are critical for
binding to RNA and report their relative contribution to binding.
We have also explored the contribution of the 59 phosphates to
RNA binding and found that the 59 b- and a- phosphates are
critical for diphosphorylated RNA binding to the capping enzyme.
Materials and Methods
Expression and purification of flavivirus capping enzyme
proteins
Recombinant dengue virus type 2, yellow fever virus, and West
Nile virus capping enzymes were previously described [7,11].
Dengue capping enzyme was produced in BL21 (DE3) pLysS E.
coli cells (Novagen). Cultures (750 ml) were induced with 400 mM
IPTG overnight at 22uC, and the bacterial pellets were collected
and stored at 280uC in low imidizole lysis buffer. Frozen pellets
were thawed and lysed with a M-110-L Pneumatic microfluidizer
(Microfluidics Inc.), and the lysate was clarified by centrifugation
at 18 K RPM in a SS-24 rotor and filtered through a 0.22 mM
syringe filter. The histidine-tagged protein was purified from
clarified lysates using a Hi-Trap Nickel column (GE Healthcare)
on an AKTA Purifier FPLC system. The eluted proteins were
concentrated using 10 K Amicon Ultra concentrators (Millipore),
and buffer exchanged into 400 mM NaCl, 20 mM Tris-Base
pH 7.5, 0.02% sodium azide, 20% glycerol, and 5 mM Tris(2-
Carboxyethyl) phosphine hydrochloride (TCEP-HCl) on a Super-
dex 200 gel filtration column (Amersham). Purified proteins were
concentrated using 10 K Amicon Ultra concentrators to 100 mM
and the concentrations were determined by the absorbance at
280 nm on a NanoDrop 2000 spectrophotometer (Nanodrop,
Inc.) using extinction coefficients obtained from the ExPASy web
site. Isolated proteins were .98% pure as estimated from SDS-
PAGE and Coomassie Blue staining.
Fluorescence Polarization RNA binding assay
Fluorescence polarization (FP) RNA binding assays were
performed with purified wild-type and mutant dengue 2 capping
enzymes and 39-fluoroscein (FAM) labeled 5-base RNAs (59
ppAGUAA-FAM, 59 pAGUAA-FAM, 59 AGUAA-FAM). The
RNAs were chemically synthesized (Biosynthesis, Inc), HPLC
purified, and verified by mass spectrometry. SAM and SAH were
purchased from New England Biolabs. GTP, ATP, GDP, and
GMP were purchased from Sigma-Aldrich. All FP experiments
were performed in 50 ml volumes in black 384-well microtiter
plates. Binding reactions were carried out in final concentrations
of 50 mM Tris pH 7.5, 0.1% NP-40, 2 mM DTT, 50 mM NaCl,
and 50 nM RNA. Wild-type and mutant dengue capping enzymes
were serially diluted in 400 mM NaCl, 50 mM Tris pH 7.5, and
2 mM DTT and added to the RNA mix. The binding reactions
were incubated at 28uC for 1 hr, then FP and total fluorescence
signals were detected using a Victor 3 V multimode platereader
set to 28uC (Perkin Elmer). All FP experiments were performed in
triplicate with free RNA and total bound RNA controls. KD values
for RNA binding were determined using Kalidagraph (Synergy
Software) using an equation based on [24]. In cases where the
curves did not reach saturation, we used the average milli-
polarization (mP) values for fully bound control samples and force-
fitted the curves to those values to estimate KD. ppAGUAA-FAM
and pAGUAA-FAM had average free and bound mP values of
125 mP and 325 mP, respectively, whereas AGUAA-FAM had
average free and bound values of 155 mP and 425 mP.
Structural Alignment and visualization
Structural alignment of the dengue virus capping enzyme (PDB
code: 2P1D) with the Vaccinia VP39 methyltransferase domain
(PDB code: 1AV6) was performed with the TopMatch Alignment
Server (http://topmatch.services.came.sbg.ac.at) [25,26]. Struc-
tural figures were generated with the PyMOL Molecular Graphics
System [27].
Results
Development of the fluorescence polarization RNA
binding assay
We established a fluorescence polarization-based RNA binding
assay to monitor binding of the capping enzyme to the 59 end of
the genomic RNA. The 59 end of the dengue, yellow fever, and
West Nile virus genomic RNA is conserved as an ‘‘59-AG(U/A)’’
sequence, and we observed that a 59 ppAG terminated RNA not
related to a flavivirus 59 UTR can be capped by the capping
enzyme [7], indicating that only the very 59 base sequences of the
RNA are necessary for the GTase reaction and that RNA
structures important for MTase activity are not necessary for the
RNA guanyltransfer step [16,17]. We have used short 5 base
AGUAA RNAs with different 59 ends (59ppAGUAA, 59pAGUAA,
or 59AGUAA) and 39 6-carboxyfluorescein (FAM) as tools to
monitor binding in solution. These RNAs show a polarization of
115–130 mP units in solution when unbound to the capping
enzyme, but upon binding polarization signal increases to ,330
mP. We use this assay in a similar manner to our GTP binding
assays described previously [11] and can very accurately and easily
monitor RNA binding to the capping enzyme.
Dengue Capping Enzyme RNA Binding
PLoS ONE | www.plosone.org 2 October 2011 | Volume 6 | Issue 10 | e25795We first determined the KD for ppAGUAA RNA binding to
dengue 2, yellow fever, and West Nile virus capping enzymes. We
obtained similar KD values for ppAGUAA bound to the dengue
and West Nile virus proteins (KD=18766 nM, and 13668n M
respectively; Figure 1) and slightly weaker to the yellow fever virus
capping enzyme (KD=420620 nM, Figure 1). The RNA binds
similarly between the three viruses, so we chose to focus on the
dengue capping enzyme for the remainder of the project due to its
ease of purification and the availability of mutants from our
previous work [7,11].
Effects of 59 phosphates on RNA binding
The presence of two additional phosphates at the 59 end of the
viral RNA likely contribute to the overall binding affinity between
the RNA and the capping enzyme. To determine what roles the a-
and b-phosphates at the 59 end of the RNA play in binding, we
determined the affinities of ppAGUAA, pAGUAA, and AGUAA
RNAs for binding wild-type dengue capping enzyme (18766 nM,
967688 nM, and 3.860.2 mM respectively) (Figure 2). The Hill
slopes of the ppAGUAA and pAGUAA curves are 1.37 and 1.46
as compared to 1.1 for AGUAA, which may indicate very weak
positive cooperativity in binding for the 59 phosphorylated species.
However, the Hill slopes for West Nile and yellow fever capping
enzymes in Figure 1 were both ,1.1, so the increased Hill slopes
observed in Figure 2 may be dengue specific. These data indicate
that the 59 terminal phosphates contribute significantly to RNA
binding, and the a- and b-phosphates both contribute to binding
affinity, although b-phosphate appears to contribute more
significantly to binding affinity.
Structural superposition of the Vaccinia Virus VP39 with
the yellow fever capping enzyme
The flavivirus capping enzyme does not have structural
homology to known GTases but does have significant structural
homology to methyltransferase enzymes. We performed a
TopMatch structural alignment with the Vaccinia virus VP39
methyltransferase protein (PDB code: 1AV6) [28] which was
crystallized with a bound capped RNA, and the dengue virus
capping enzyme in complex with GTP (PDB code: 2P1D)
(Figure 3). The alignment showed strong structural homology in
the methyltransferase section of the capping enzyme (Figure 3A),
but more interestingly the bound cap/GTP and SAH ligands were
in very similar positions in both structures, and the RNA bound in
1AV6 is in close proximity to the basic patch of residues that has
been postulated to be the RNA binding site (Figure 3B). Residues
K32, K41, and K175 in the VP39 structure (1AV6) appear to
interact with the phosphates of the RNA. Dengue virus capping
enzyme residues K62, K181, and R212/K29/K30 appear to
structurally overlap with VP39 residues K41, K175, and K32,
respectively. The R212/K29/R30 cluster is slightly farther away
from the RNA than VP39 K32 (Figure 3C), but would strongly
interact with the RNA if it bent towards the residues. K181
(dengue) appears to structurally clash with the RNA ribose group
in the 1AV6 structure, whereas K175 (VP39) interacts with the
Figure 1. Comparison of dengue, yellow fever, and West Nile virus capping enzyme KD values for ppAGUAA-FAM RNA. 50 nM
ppAGUAA-FAM RNA was incubated in increasing concentrations of wild-type capping enzyme for 1 hr, then fluorescence polarization signal was
detected. Curve fits and KD values were determined with the KaleidaGraph software package as described in the methods section. n=3.
doi:10.1371/journal.pone.0025795.g001
Dengue Capping Enzyme RNA Binding
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be pushed away from its position in the VP39 structure to
accommodate binding to K181.
Mutational Analysis of dengue virus capping enzyme
RNA binding
Based on the structural alignment of VP39 and the dengue virus
capping enzyme, we performed a mutagenesis analysis of the
dengue capping enzyme to evaluate individual residue contribu-
tions to RNA binding. Protein:RNA interactions commonly occur
between basic residues (Arg and Lys) interacting with phosphates
within and at the end of the RNA. The region between the GTP
and SAM binding site on the capping enzyme is rich with basic
residues, and has been hypothesized to be the RNA binding site.
To examine the contribution of residues to RNA binding, we
individually mutated conserved and semi-conserved (eg. K/R)
residues on the GTP/SAM binding face of the capping enzyme
and determined how each mutation affected binding affinity di-,
mono-, and unphosphorylated RNAs (Table 1).
We observed that mutation of residues F25, K30, R57, K181,
and R212 reduced the binding affinity to the greatest extent of all
residues tested (#5-fold reduction of KD (Table 2)). The remaining
mutations had little effect on RNA binding affinity. K62A in the
proposed RNA bind site did not affect RNA binding with any
RNA species, indicating that it is not involved in binding RNA.
K30A appeared to have a strong effect on binding with
ppAGUAA and AGUAA, indicating that it interacts with a
phosphate present in both RNA species, most likely the phosphate
between the A and G bases of the AGUAA RNA. F25A was
initially added as a control because it interacts with the guanosine
cap that is not present on the RNAs in this study. However, we
observed that the mutant had significantly reduced binding to
ppAGUAA RNA but no significant effect on pAGUAA and
AGUAA binding. The phenylalanine group likely does not
interact directly with the RNA, but a possible explanation is that
mutation to alanine alters the position of helix A2 and moves K30
out of the optimal position to keep the 59 diphosphate in line with
other binding residues. R57A appeared to have its greatest effect
when binding to ppAGUAA but less effect with pAGUAA and
AGUAA, suggesting that R57 may interact predominately with
the b-phosphate of the diphosphorylated RNA. K181A severely
reduced ppAGUAA binding but had greatly reduced effects on
pAGUAA and AGUAA binding, suggesting that K181 strongly
interacts with the b-phosphate. R212A showed significant effects
with binding to ppAGUAA and mild effects on pAGUAA binding
(2.8 fold), suggesting that R212 interacts primarily with the b-
phosphate but may weakly interact with the a-phosphate. In
summary, based on these experiments R57, K181, and R212
likely interact with the b-phosphate, R212 may interact with the a-
or b-phosphate, and K30 may interact with the phosphate
between the A and G bases.
Effects of GTP and SAM on RNA binding affinity
Diphosphorylated RNA is one of three ligands involved in the
guanyltransferase and methyltransferase reactions, the other two
being GTP and SAM. We assessed the effects of GTP and SAM on
RNA binding to wild-type dengue capping enzyme to determine if
either could positively or negatively affected binding affinity. We
Figure 2. Effects of 59 RNA phosphates on dengue capping enzyme binding affinity. 50 nM of AGUAA-FAM, pAGUAA-FAM, and ppAGUAA-
FAM was incubated with increasing concentrations of wild-type dengue capping enzyme for 1 hr, then fluorescence polarization signal was detected.
n=3.
doi:10.1371/journal.pone.0025795.g002
Dengue Capping Enzyme RNA Binding
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amounts of GTP, GDP, GMP, and ATP (Figure 4A). We observed
that high concentrations of GTP and ATP (50 mM) significantly
weakened ppAGUAA binding (KD=,18 mM), whereas GDP had
a moderate affect on ppAGUAA binding binding (KD=,3 mM)
and GMP had a very minor effect on ppAGUAA binding
Figure 3. Structural superposition of the Vaccinia virus VP39 with the dengue virus capping enzyme. A) Global overlap of 1AV6 (VP39)
and 2P1D (dengue virus capping enzyme). Superposition was performed using the TopMatch webserver, and figures were generated in PyMol. Red/
orange indicate structural overlap between 1AV6 and 2P1D. Non-overlapping regions are not shown. Bound GTP/Cap and SAH are shown. RNA has
been removed for clarity. B) Overlay of bound ligands from 1AV6 (green) and 2P1D (magenta). C) Overlap of 1AV6 residue K32 (interacting with RNA
phosphate #6) to 2P1D residues K29, K30, and R212. D) Overlap of 1AV6 residues K41 (interacting with RNA phosphate #4) and K175 (interacting
with RNA ribose #1 hydroxyl) to 2P1D K62 and K181, respectively.
doi:10.1371/journal.pone.0025795.g003
Table 1. Binding affinities of mutant dengue capping enzyme proteins for different diphosphorylated RNA species and GTP.
AGUAA pAGUAA ppAGUAA GTP
Mutant Average KD SD Average KD SD Average KD SD Average KD SD
WT 3.7 mM 217 nM 967 nM 88 nM 187 nM 6 nM 77 nM 4 nM
K22A 3.9 mM 470 nM 862 nM 201 nM 689 nM 450 nM 120 nM 24 nM
F25A 6.0 mM 687 nM 1.8 mM 440 nM 1.4 mM 501 nM 4.6 mM 495 nM
K29A 4.1 mM1 . 0 mM 1.4 mM 75 nM 652 nM 59 nM 609 nM 154 nM
K30A 18.5 mM4 . 7 mM 1.8 mM 243 nM 4.0 mM 778 nM 133 nM 41 nM
E35A 3.4 mM 813 nM 524 nM 69 nM 247 nM 30 nM 67 nM 15 nM
R57A 2.1 mM 462 nM 735 nM 137 nM 2.66 mM 775 nM 78 nM 17 nM
G58A 2.9 mM 337 nM 687 nM 71 nM 641 nM 54 nM 85 nM 36 nM
K62A 5.5 mM 299 nM 1.3 mM 649 nM 305 nM 122 nM 271 nM 59 nM
K181A 8.5 mM2 . 0 mM 2.75 mM 742 nM 4.6 mM1 . 9 mM 359 nM 32 nM
R212A 7.9 mM 845 nM 1.6 mM 79 nM 1.0 mM 222 nM 193 nM 31 nM
50 nM of the indicated AGUAA-FAM, pAGUAA-FAM, ppAGUAA-FAM, or 10 nM GTP-Bodipy were incubated with increasing concentrations of the indicated protein for
1h ra t2 8 uC then fluorescence polarization signal was detected. KD and standard deviation values are reported for each. n=3.
doi:10.1371/journal.pone.0025795.t001
Dengue Capping Enzyme RNA Binding
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binding (an 80 fold reduction in binding) as compared to GDP and
GMP levels suggest that the c- and b-phosphates on the nucleotides
compete with the diphosphate on the RNA for binding. To further
examine if the GTP b- and c- phosphates compete with
diphosphorylated RNA binding, we determined the affinity of
AGUAA RNA in the presence of 50 mM GTP. We observed that
AGUAA binding was weakened 2.4 fold in the presence of 50 mM
GTP (KD (Mock)=3.5 mM, KD (50 mM GTP)=8.4 mM), indicat-
ing that GTP had only minor effects on AGUAA binding. These
results suggest that the GTP phosphates interfere with the
diphosphate on the ppAGUAA RNA during binding.
To examine the effect of SAM and the post-methylation
product SAH, we determined the KD of ppAGUAA binding to the
dengue capping enzyme in the presence of increasing amounts of
SAM or SAH (Figure 4B). At low concentrations of SAM and
SAH we observed no effect of either SAM or SAH on ppAGUAA
binding affinity (KD=,200 nM), but we did observe a slight
increasing in ppAGUAA RNA affinity in the presence of
increasing concentrations of both SAM and SAH. A slightly
stronger effect on RNA binding affinity was evident with SAM
than SAH, suggesting that SAM was able to stabilize RNA binding
slightly better than SAH.
Mapping diphosphorylated RNA binding to the flavivirus
capping enzyme
Based on our biochemical data, we mapped residues that
significantly interacted with RNAs on RNA binding residues on
the dengue virus capping enzyme in complex with GTP (PDB
code: 2P1D). Figure 5 shows residues that were tested in this
manuscript, and color codes the effects of each residue on RNA
binding. Residues K22, K29, E35, and R62 had minimal effects
on RNA binding (magenta), whereas residues F25, K30, R57,
K181, and R212 (green) had significant effects on binding affinities
(reduction greater than 5-fold). A clear clustering around the base
of helix A2 is apparent, and suggests that the diphosphorylated
RNA may enter the capping enzyme to be capped through the
groove region between helices A2 and A3.
Discussion
In this study we performed a detailed characterization of the
RNA binding characteristics of the dengue 2 capping enzyme. We
present data demonstrating that dengue, yellow fever, and West
Nile virus capping enzyme proteins bind 59 diphosphorylated end
of the viral RNA with similar affinity, although yellow fever virus
capping enzyme bound RNA with 2-fold weaker affinity than
dengue or West Nile virus capping enzymes. The yellow fever
virus capping enzyme has an arginine at position 30 whereas the
dengue and West Nile virus capping enzymes have a lysine at
position 30, which may explain the small difference in affinity
between the viruses (Figure 1). Based on our biochemical and
mutagenesis data, we present a preliminary model for capping
enzyme binding to the 59 diphosphorylated end of the viral
genomic RNA strand (Figure 5). The mechanism of action for the
guanylyltransferase and methyltransferase activities of the flavivi-
rus NS5 capping enzyme have been the focus of intensive study
since the dengue capping enzyme structure was solved in 2002
[8,13,16,17]. Most of the effort has been focused on understanding
the methyltransferase function. Because how the GTase activity
within the capping enzyme functions is unknown, understanding
how the capping enzyme binds one of its GTase substrates will
help clarify how the enzyme works.
The overlap of the Vaccinia VP39 protein with the dengue
capping enzyme is very strong in the methyltransferase region of
the capping enzyme as had been previously noted, and
superposition and alignment of residues involved in RNA cap
binding have been described [8]. The location of the SAH in both
structures is almost identical, and the GTP in the dengue virus
capping enzyme is in close proximity to the cap structure in VP39.
An obvious difference between the two structures is that the GTP/
Cap structures are flipped in respect to each other, indicating
differing modes of guanine recognition. The VP39 cap and the
dengue virus capping enzyme GTP are shifted approximately 5 A ˚
from each other, indicating that a capped RNA bound to the
dengue virus capping enzyme would also be shifted ,5A ˚ from
where the RNA in the VP39 structure is situated.
Mutation of K62 in the dengue capping enzyme did not affect
RNA binding, whereas the homologous lysine residue in the
Vaccinia virus VP39 did interact with a phosphate (Figure 3D).
K181 mutation strongly affected binding, suggesting that the
superposition was partially correct. We observed a steric clash
between K181 and the superimposed VP39 RNA, suggesting that
the mode of K181 (dengue) interaction with RNA may be
somewhat different than K175 (VP39) binding to the ribose of the
first RNA nucleotide. The dramatic effect of mutating K30 on
Table 2. Comparison of RNA and GTP binding affinities.
Mutant Ratio Mutant/WT AGUAA KD Ratio Mutant/WT pAGUAA KD Ratio Mutant/WT ppAGUAA KD Ratio Mutant/WT GTP KD
WT 1.0 1.0 1.0 1.0
K22A 1.1 0.9 3.7 1.6
F25A 1.6 1.9 7.3 60.3
K29A 1.1 1.4 3.5 7.9
K30A 5.0 1.9 21.2 1.7
E35A 0.9 0.5 1.3 0.9
R57A 0.6 0.8 14.2 1.0
G58A 0.8 0.7 3.4 1.1
K62A 1.5 1.3 1.6 3.5
K181A 2.3 2.8 24.5 4.7
R212A 2.1 1.7 5.5 2.5
Fold change was determined for RNA binding by comparing each mutant KD value to wild-type (WT) ligand binding value from Table 1.
doi:10.1371/journal.pone.0025795.t002
Dengue Capping Enzyme RNA Binding
PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e25795Figure 4. Effects of capping enzyme ligands on RNA binding. A) Effect of purine nucleotides on ppAGUAA-FAM and AGUAA-FAM RNA
binding. KD values for ppAGUAA binding to wild-type dengue capping enzyme were determined in the presence of increasing concentrations of the
indicated nucleotide. AGUAA binding was determined only in the presence of 50 mM GTP or Mock. B) Effect of SAM and SAH on ppAGUAA-FAM RNA
binding affinity. n=3.
doi:10.1371/journal.pone.0025795.g004
Figure 5. RNA binding residues on the dengue capping enzyme. All residues that were tested in this study were mapped on the dengue virus
capping enzyme structure (2P1D) bound to GTP [11]. A) Residues that showed greater than 5-fold reduction in RNA binding affinity against AGUAA,
pAGUAA, or ppAGUAA are colored in green. Residues that showed less than 5-fold reduction in binding affinity against AGUAA, pAGUAA, or
ppAGUAA are colored in magenta. Bound GTP and SAH are shown. B) Surface representation of 2P1D with RNA binding residues colored green and
non-binding residues colored magenta.
doi:10.1371/journal.pone.0025795.g005
Dengue Capping Enzyme RNA Binding
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RNA. VP39 K32, which partially overlaps with the K29/K30/
R212 cluster, interacts with a phosphate, but K30 and R212 are
situated about 5 A ˚ away from the superimposed RNA. The lack of
effect by mutating K62 and the strong effect by mutating K30 and
R212 (to a lesser extent) suggest that the RNA is pulled back
toward K30/R212 and away from K62 in the dengue capping
enzyme structure. Supporting these observations is the effect seen
on diphosphorylated RNA binding to the F25A mutant. This
mutation severely affects GTP binding, but also appears to
significantly affect RNA binding. Removing a hydrophobic
phenylalanine likely perturbs the stability of the helix A2 (K30 is
at the base of helix A2 (Figure 5)) and potentially reduces K30
binding the RNA by reducing its stability or moving it out of
optimal binding position. Combining the differences in the
locations of the cap and GTP with the effects on binding seen
with K30 and R212 but not K62 suggests that the capped RNA
would wrap tightly around helix A2 in the capping enzyme and
have little to no interaction with the SAM binding face of the
capping enzyme. This does not preclude the RNA ribose hydroxyl
groups from being in an appropriate position to undergo 29-O
methylation, but additional structural studies would need to be
performed to determine their positions.
Addition of GTP and ATP to the ppAGUAA-FAM binding
experiments showed that the phosphates on the nucleotides are
able to compete with diphosphorylated RNA binding, and that
reducing the number of phosphates on the nucleoside reduces the
observed competitive effect. We also observed that high concen-
trations of GTP had only minor effects on the binding of an
unphosphorylated AGUAA RNA, suggesting that GTP predom-
inately interferes with diphosphate binding. The position of GTP
binding to the capping enzyme is well known [8,11], and GTP
phosphates interact with several residues that are also involved in
RNA interaction based on this study. R212 and K181 bind to
GTP phosphates as well as to RNA (Table 1 and [11]), suggesting
that the residues could interact with GTP or RNA at different
times during capping. Since GTP was able to displace dipho-
sphorylated RNA from the capping enzyme, it is likely that the
capping enzyme would first bind GTP and form a guanylated
protein intermediate prior to interacting with the diphosphory-
lated RNA to form the cap. This could inform the order of
substrate binding during the GTase reaction, which would help
with the development of a catalytic mechanism for the GTase.
The small increase in ppAGUAA-FAM affinity that was observed
in the presence of SAM suggests either that SAM stabilizes the
interaction between the RNA and the capping enzyme or that
SAM transfers a methyl group to the RNA that increases the
affinity of the RNA for the capping enzyme. The effect observed
with SAM may have a component of each situation, as SAH
(which cannot methylate the RNA) show a weak stabilizing effect
on RNA binding. We are currently testing if the diphosphorylated
RNA is methylated in the presence of SAM by mass spectrometry.
If we determine that the diphosphorylated RNA substrate is
methylated in the presence of SAM, it would suggest that the
genomic RNA may be methylated at the 29-O position prior to
RNA capping, providing important information about the order of
cap formation.
These studies provide a solid foundation for further exploration
into how the flavivirus capping enzymes bind to the 59
diphosphorylated end of the viral genomic RNA during RNA
capping. It provides a starting point for further investigations into
to determinants of RNA binding, such as further clarifying which
sidechains interact with which phosphate, determining the role of
ribose hydroxyls in binding, and the specificity for guanine versus
adenine in the first nucleotide position during capping [7].
Additional studies will help clarify these questions. Testing
ppAGUAA-FAM RNAs with specific methylphosphanate substi-
tutions in combination with capping enzyme mutants would help
to map out specific amino acid:phosphate interactions [29].
Substituting ribose groups with 29 deoxy ribose at specific positions
in the RNA would allow for an examination of hydroxyl
interactions with specific amino acids. Substitution of each base
in the AGUAA RNA with analogs (eg. ppIGUAA-FAM, where
I=inosine) would be critical for understanding the correlates of
adenine vs. guanine specificity for capping the RNA [7]. With
these data, molecular docking experiments could be performed
that take into account the various distance restraints to build a
biochemically-derived model of RNA binding. Our increased
understanding of how the flavivirus capping enzyme binds to the
substrates it uses to cap the genome will aid in our understanding
of how this non-canonical capping enzyme functions, and will be
valuable for the development of rationally designed capping
enzyme specific drugs.
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